HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wei Xue Selected Research

ethinyl estradiol drug combination Cyproterone acetate

12/2020Is There An Advantage of Using Dingkun Pill () alone or in Combination with Diane-35 for Management of Polycystic Ovary Syndrome? A Randomized Controlled Trial.
4/2019Insulin Resistance in Polycystic Ovary Syndrome Improved by Chinese Medicine Dingkun Pill (): A Randomized Controlled Clinical Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wei Xue Research Topics

Disease

128Neoplasms (Cancer)
01/2023 - 03/2006
62Prostatic Neoplasms (Prostate Cancer)
06/2022 - 03/2006
30Renal Cell Carcinoma (Grawitz Tumor)
01/2023 - 04/2015
22Neoplasm Metastasis (Metastasis)
04/2022 - 04/2015
13Urinary Bladder Neoplasms (Bladder Cancer)
01/2022 - 05/2011
13Inflammation (Inflammations)
01/2022 - 02/2006
10Breast Neoplasms (Breast Cancer)
09/2021 - 01/2016
8Kidney Neoplasms (Kidney Cancer)
06/2022 - 06/2014
8Infections
06/2022 - 02/2006
8Carcinoma (Carcinomatosis)
01/2022 - 10/2010
7Wounds and Injuries (Trauma)
01/2022 - 01/2013
7Carcinogenesis
01/2022 - 01/2014
7Glioma (Gliomas)
01/2022 - 01/2016
6Hemolysis
09/2021 - 04/2014
6Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
01/2021 - 10/2016
5Ischemia
01/2020 - 06/2015
4Disease Progression
02/2022 - 04/2017
4Mycoses (Diseases, Fungus)
01/2022 - 01/2016
4Hypoxia (Hypoxemia)
10/2021 - 12/2013
4Hypertension (High Blood Pressure)
01/2021 - 09/2006
4Glioblastoma (Glioblastoma Multiforme)
01/2021 - 10/2017
4Melanoma (Melanoma, Malignant)
10/2020 - 01/2018
4Burns
08/2018 - 07/2014
3Hypotension (Low Blood Pressure)
01/2022 - 10/2020
3Hypersensitivity (Allergy)
01/2022 - 01/2016
3Cognitive Dysfunction
10/2021 - 09/2009
3Reperfusion Injury
01/2021 - 01/2019
3Hemorrhage
01/2021 - 12/2007
3Osteosarcoma (Osteogenic Sarcoma)
01/2021 - 04/2019
3Rheumatoid Arthritis
01/2021 - 01/2019
3Cystic Fibrosis (Mucoviscidosis)
01/2020 - 02/2006

Drug/Important Bio-Agent (IBA)

20Proteins (Proteins, Gene)FDA Link
02/2022 - 12/2013
20Pharmaceutical PreparationsIBA
12/2021 - 01/2013
16Biomarkers (Surrogate Marker)IBA
08/2022 - 10/2016
12Small Interfering RNA (siRNA)IBA
09/2021 - 04/2014
10Biological ProductsIBA
01/2022 - 06/2014
10Peptides (Polypeptides)IBA
01/2022 - 01/2016
10AndrogensIBA
01/2022 - 10/2010
10Docetaxel (Taxotere)FDA Link
01/2022 - 04/2014
10CytokinesIBA
01/2021 - 03/2014
9MicroRNAs (MicroRNA)IBA
07/2022 - 12/2013
9HydrogelsIBA
12/2021 - 10/2013
8Glucose (Dextrose)FDA LinkGeneric
01/2021 - 10/2016
7Messenger RNA (mRNA)IBA
07/2022 - 01/2016
7Long Noncoding RNAIBA
07/2022 - 04/2016
7Indicators and Reagents (Reagents)IBA
06/2022 - 01/2016
7VaccinesIBA
01/2022 - 11/2014
7DNA (Deoxyribonucleic Acid)IBA
01/2021 - 03/2008
6Circular RNAIBA
01/2022 - 07/2017
6Lysine (L-Lysine)FDA Link
02/2021 - 04/2014
6Hormones (Hormone)IBA
01/2021 - 12/2016
6Doxorubicin (Adriamycin)FDA LinkGeneric
10/2020 - 03/2014
5Tyrosine Kinase InhibitorsIBA
08/2022 - 01/2017
5Transcription Factors (Transcription Factor)IBA
06/2022 - 01/2018
5Sunitinib (Sutent)FDA Link
04/2022 - 08/2017
5EnzymesIBA
01/2022 - 01/2016
5Therapeutic UsesIBA
01/2022 - 12/2018
5Prostate-Specific Antigen (Semenogelase)IBA
01/2022 - 01/2016
5Oxygen (Dioxygen)IBA
12/2021 - 01/2018
5Interleukin-6 (Interleukin 6)IBA
10/2021 - 01/2019
5abirateroneIBA
01/2021 - 01/2017
5AlbuminsIBA
01/2020 - 01/2017
5AminesIBA
09/2019 - 03/2008
4CholesterolIBA
01/2022 - 03/2006
4Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2022 - 01/2020
4AzolesIBA
01/2022 - 01/2016
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 03/2017
4AntigensIBA
12/2020 - 10/2016
4EpitopesIBA
01/2019 - 02/2016
4Folic Acid (Vitamin M)FDA LinkGeneric
10/2018 - 03/2014
4PolymersIBA
12/2017 - 01/2011
3Axitinib (AG 013736)IBA
04/2022 - 10/2019
3Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 07/2014
3RNA (Ribonucleic Acid)IBA
01/2022 - 01/2020
3Norepinephrine (Noradrenaline)FDA LinkGeneric
01/2022 - 10/2020
3vitexinIBA
10/2021 - 04/2020
3Circulating Tumor DNAIBA
08/2021 - 01/2021
3Histones (Histone)IBA
02/2021 - 04/2017
3Reactive Oxygen Species (Oxygen Radicals)IBA
01/2021 - 12/2006
3Cancer VaccinesIBA
01/2021 - 11/2014
3GelatinIBA
01/2021 - 07/2014
3CateninsIBA
04/2020 - 01/2018
3Fibrinogen (Factor I)FDA Link
01/2020 - 01/2017
3Sorafenib (BAY 43-9006)FDA Link
10/2019 - 04/2015
3MicellesIBA
09/2019 - 09/2015
3Phosphopyruvate Hydratase (Enolase)IBA
01/2019 - 01/2017
3Abiraterone AcetateIBA
12/2018 - 01/2017

Therapy/Procedure

75Therapeutics
01/2023 - 05/2004
33Castration
06/2022 - 11/2014
13Drug Therapy (Chemotherapy)
01/2021 - 05/2011
11Nephrectomy
01/2023 - 06/2012
11Prostatectomy (Retropubic Prostatectomy)
01/2022 - 03/2006
8Immunotherapy
06/2022 - 11/2014
5Length of Stay
02/2022 - 04/2012
5Lasers (Laser)
07/2021 - 06/2014
5Operative Time
01/2020 - 04/2012
4Cystectomy
01/2022 - 01/2014
4Radiotherapy
01/2021 - 01/2013
3Radiofrequency Ablation
02/2022 - 01/2016
3Neoadjuvant Therapy
01/2022 - 10/2019